|
BD2 specific inhibitors mentioned in Science
|
9
|
Resverlogix Corp.
|
Mar 22, 2020 06:53AM
|
|
Re: New MD&A posted
|
1
|
Resverlogix Corp.
|
Dec 18, 2019 04:00PM
|
|
Civil vs. criminal court judgments
|
9
|
Resverlogix Corp.
|
Dec 17, 2019 10:03AM
|
|
Re: A hunch about the below median LDL-C observation
|
4
|
Resverlogix Corp.
|
Nov 20, 2019 03:34PM
|
|
Exceptionally good news
|
14
|
Resverlogix Corp.
|
Nov 18, 2019 10:21AM
|
|
Comments re AHA presentation
|
12
|
Resverlogix Corp.
|
Nov 16, 2019 06:32PM
|
|
Re: Back to the FDA
|
7
|
Resverlogix Corp.
|
Oct 04, 2019 11:37AM
|
|
Re: Their finest hour
|
9
|
Resverlogix Corp.
|
Sep 24, 2019 04:02PM
|
|
Their finest hour
|
10
|
Resverlogix Corp.
|
Sep 24, 2019 01:31PM
|
|
Re: What would a successful BETonMACE Top-Line Data Announcement Look Like?
|
4
|
Resverlogix Corp.
|
Aug 12, 2019 05:20PM
|
|
Re: What would a successful BETonMACE Top-Line Data Announcement Look Like?
|
3
|
Resverlogix Corp.
|
Aug 12, 2019 05:09PM
|
|
Re: Reata, Bardoxolone, NRF2, CKD, Mitochondria, Inflammation, Redox Balance, Reactive Oxygen Species
|
2
|
Resverlogix Corp.
|
Jun 14, 2019 05:38PM
|
|
Re: The thread has been killed
|
4
|
Resverlogix Corp.
|
Jun 12, 2019 04:18PM
|
|
Impact factors
|
8
|
Resverlogix Corp.
|
Apr 16, 2019 03:31AM
|
|
Re: Another answer from IR....
|
3
|
Resverlogix Corp.
|
Mar 05, 2019 05:21PM
|
|
Re: Important article published yesterday (January 4), RVX208 relevant
|
4
|
Resverlogix Corp.
|
Jan 05, 2019 12:23PM
|
|
Important article published yesterday (January 4), RVX208 relevant
|
13
|
Resverlogix Corp.
|
Jan 05, 2019 07:34AM
|
|
Abstract - first example of a "curative" effect?
|
10
|
Resverlogix Corp.
|
Oct 10, 2018 05:28PM
|
|
Some calculations on efficacy
|
12
|
Resverlogix Corp.
|
May 31, 2018 05:45PM
|
|
Re: ... a couple things...
|
6
|
Resverlogix Corp.
|
May 09, 2018 05:48PM
|
